Paltac Corporation (8283.T)
JPY 4370.0
(1.51%)
JPY 4370.0
(1.51%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 35.92 Billion JPY | 7.14% |
| 2022 | 33.56 Billion JPY | -2.74% |
| 2021 | 33.85 Billion JPY | 1.18% |
| 2020 | 33.65 Billion JPY | 3.93% |
| 2019 | 41.97 Billion JPY | -2.06% |
| 2018 | 33.16 Billion JPY | 8.77% |
| 2017 | 30.1 Billion JPY | 14.11% |
| 2016 | 26.64 Billion JPY | 12.37% |
| 2015 | 22.62 Billion JPY | 10.73% |
| 2014 | 21.08 Billion JPY | 0.87% |
| 2013 | 20.49 Billion JPY | 6.13% |
| 2012 | 19.47 Billion JPY | 3.59% |
| 2011 | 15.99 Billion JPY | 19.76% |
| 2010 | 10.64 Billion JPY | -7.08% |
| 2009 | 16.43 Billion JPY | 1.81% |
| 2008 | 16.97 Billion JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 9.53 Billion JPY | 53.41% |
| 2024 Q2 | 10.52 Billion JPY | 10.46% |
| 2023 Q2 | 9.41 Billion JPY | -0.7% |
| 2023 FY | - JPY | 7.14% |
| 2023 Q1 | 9.47 Billion JPY | 25.45% |
| 2023 Q4 | 7.22 Billion JPY | -30.09% |
| 2023 Q3 | 10.34 Billion JPY | 9.85% |
| 2022 Q4 | 7.55 Billion JPY | -19.57% |
| 2022 FY | - JPY | -2.74% |
| 2022 Q3 | 9.39 Billion JPY | 23.93% |
| 2022 Q1 | 8.66 Billion JPY | 12.63% |
| 2022 Q2 | 7.58 Billion JPY | -12.48% |
| 2021 Q2 | 8.33 Billion JPY | -8.57% |
| 2021 FY | - JPY | 1.18% |
| 2021 Q4 | 7.69 Billion JPY | -14.42% |
| 2021 Q3 | 8.98 Billion JPY | 7.82% |
| 2021 Q1 | 9.11 Billion JPY | 20.01% |
| 2020 FY | - JPY | 3.93% |
| 2020 Q3 | 8.97 Billion JPY | -0.42% |
| 2020 Q2 | 9.01 Billion JPY | 10.63% |
| 2020 Q1 | 8.14 Billion JPY | 11.86% |
| 2020 Q4 | 7.59 Billion JPY | -15.36% |
| 2019 Q1 | 8.17 Billion JPY | 20.31% |
| 2019 Q2 | 9.38 Billion JPY | 14.83% |
| 2019 FY | - JPY | -2.06% |
| 2019 Q4 | 7.28 Billion JPY | -4.45% |
| 2019 Q3 | 7.62 Billion JPY | -18.76% |
| 2018 Q2 | 8.53 Billion JPY | -1.67% |
| 2018 FY | - JPY | 8.77% |
| 2018 Q3 | 9.12 Billion JPY | 6.89% |
| 2018 Q1 | 8.68 Billion JPY | 41.21% |
| 2018 Q4 | 6.79 Billion JPY | -25.59% |
| 2017 FY | - JPY | 14.11% |
| 2017 Q3 | 8.24 Billion JPY | -1.4% |
| 2017 Q4 | 6.14 Billion JPY | -25.46% |
| 2017 Q1 | 7.7 Billion JPY | 48.03% |
| 2017 Q2 | 8.36 Billion JPY | 8.62% |
| 2016 Q1 | 6.58 Billion JPY | 15.54% |
| 2016 Q3 | 7.04 Billion JPY | -10.34% |
| 2016 Q4 | 5.2 Billion JPY | -26.17% |
| 2016 FY | - JPY | 12.37% |
| 2016 Q2 | 7.86 Billion JPY | 19.31% |
| 2015 Q4 | 5.7 Billion JPY | -9.0% |
| 2015 FY | - JPY | 10.73% |
| 2015 Q3 | 6.26 Billion JPY | -0.67% |
| 2015 Q2 | 6.3 Billion JPY | 15.05% |
| 2015 Q1 | 5.48 Billion JPY | 5.63% |
| 2014 Q3 | 5.66 Billion JPY | -6.04% |
| 2014 Q2 | 6.02 Billion JPY | 31.66% |
| 2014 Q1 | 4.57 Billion JPY | -11.06% |
| 2014 FY | - JPY | 0.87% |
| 2014 Q4 | 5.19 Billion JPY | -8.32% |
| 2013 Q3 | 5.34 Billion JPY | -8.89% |
| 2013 Q4 | 5.14 Billion JPY | -3.76% |
| 2013 FY | - JPY | 6.13% |
| 2013 Q1 | 4.9 Billion JPY | 7.75% |
| 2013 Q2 | 5.86 Billion JPY | 19.56% |
| 2012 Q4 | 4.55 Billion JPY | -6.04% |
| 2012 Q1 | 4.83 Billion JPY | 19.73% |
| 2012 Q2 | 5.8 Billion JPY | 19.91% |
| 2012 Q3 | 4.84 Billion JPY | -16.4% |
| 2012 FY | - JPY | 3.59% |
| 2011 Q2 | 5.66 Billion JPY | 26.24% |
| 2011 Q1 | 4.48 Billion JPY | 40.15% |
| 2011 FY | - JPY | 19.76% |
| 2011 Q3 | 5.15 Billion JPY | -9.09% |
| 2011 Q4 | 4.04 Billion JPY | -21.58% |
| 2010 Q1 | 3.79 Billion JPY | 26.45% |
| 2010 Q3 | 4.25 Billion JPY | -12.77% |
| 2010 FY | - JPY | -7.08% |
| 2010 Q4 | 3.2 Billion JPY | -24.76% |
| 2010 Q2 | 4.88 Billion JPY | 28.56% |
| 2009 Q3 | 3.32 Billion JPY | 0.0% |
| 2009 FY | - JPY | 1.81% |
| 2009 Q4 | 3 Billion JPY | -9.61% |
| 2008 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Kitanotatsujin Corporation | 1.58 Billion JPY | -2162.286% |
| Euglena Co., Ltd. | 676 Million JPY | -5214.053% |
| BEAUTY GARAGE Inc. | 1.96 Billion JPY | -1728.301% |
| Axas Holdings Co.,Ltd. | 555.75 Million JPY | -6363.785% |
| C.I. Medical Co.,Ltd. | 4.01 Billion JPY | -795.166% |
| Kao Corporation | 154.49 Billion JPY | 76.748% |
| Niitaka Co., Ltd. | 1.36 Billion JPY | -2523.03% |
| Rohto Pharmaceutical Co.,Ltd. | 48.85 Billion JPY | 26.469% |
| Shiseido Company, Limited | 106.46 Billion JPY | 66.257% |
| Lion Corporation | 42.31 Billion JPY | 15.104% |
| Mandom Corporation | 6.69 Billion JPY | -436.244% |
| Ivy Cosmetics Corporation | 242.6 Million JPY | -14707.502% |
| Milbon Co., Ltd. | 7.8 Billion JPY | -360.526% |
| Nippon Shikizai, Inc. | 1.28 Billion JPY | -2687.806% |
| Fancl Corporation | 16.6 Billion JPY | -116.365% |
| KOSÉ Corporation | 26.85 Billion JPY | -33.757% |
| Cota Co., Ltd. | 2.26 Billion JPY | -1483.58% |
| HABA Laboratories,Inc. | -1.31 Billion JPY | 2833.221% |
| C'bon Cosmetics Co.,Ltd. | 171.84 Million JPY | -20804.06% |
| Pola Orbis Holdings Inc. | 23.17 Billion JPY | -54.994% |
| Noevir Holdings Co., Ltd. | 12.24 Billion JPY | -193.393% |
| Adjuvant Holdings Co.,Ltd. | 124 Million JPY | -28870.161% |
| Almado, Inc. | 983.21 Million JPY | -3553.615% |
| I-ne CO., LTD. | 4.7 Billion JPY | -664.319% |
| Premier Anti-Aging Co., Ltd. | -627 Million JPY | 5829.346% |
| Liberta Co.,Ltd. | 318.19 Million JPY | -11189.724% |
| AXXZIA Inc. | 1.28 Billion JPY | -2692.287% |
| S.T. Corporation | 2.62 Billion JPY | -1267.974% |
| Kobayashi Pharmaceutical Co., Ltd. | 31.68 Billion JPY | -13.379% |
| Earth Corporation | 10.6 Billion JPY | -238.641% |
| Sagami Rubber Industries Co., Ltd. | 1.09 Billion JPY | -3182.0% |
| Asahi Eito Holdings Co.,Ltd. | -573.98 Million JPY | 6358.57% |
| Ya-Man Ltd. | 1.43 Billion JPY | -2400.259% |
| MTG Co., Ltd. | 4.39 Billion JPY | -717.547% |
| TRANSACTION CO.,Ltd. | 5.8 Billion JPY | -518.375% |
| SHOBIDO Corporation | 1.11 Billion JPY | -3135.735% |
| Artnature Inc. | 3.78 Billion JPY | -848.587% |
| Pigeon Corporation | 15.8 Billion JPY | -127.274% |
| Unicharm Corporation | 178.01 Billion JPY | 79.82% |
| CB GROUP MANAGEMENT Co., Ltd. | 3.28 Billion JPY | -993.546% |